Prosecution Insights
Last updated: November 04, 2026

Zentek Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Zentek Ltd. currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The company's active prosecution is limited to a distinct examiner and a distinct art unit, indicating a focused interaction with the patent office. This concentration suggests that the company's current intellectual property efforts are centered on a specific technical area within biotechnology that is overseen by a single expert group.

MATTISON, LORI K is the busiest examiner for the portfolio, handling the 1 busiest examiner pending action. As the only examiner currently reviewing the company's pending work, their specific approach to the Biotechnology & Pharmaceuticals field will be the primary factor in the portfolio's immediate progress. Practitioners should analyze the examiner's historical data and art unit trends to craft a response that effectively addresses the pending office action.

With a distinct examiner involved, the administrative complexity of the portfolio is low, allowing for a very direct prosecution strategy. However, this also means that the company's current patenting goals in the Biotechnology & Pharmaceuticals area are entirely dependent on the resolution of this single matter. Successfully navigating the requirements of MATTISON, LORI K is essential for Zentek Ltd. to advance its patent position and clear its current pending workload.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MATTISON, LORI K 1 15.2% +27.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18259010 GRAPHENE OXIDE-CATIONIC SILVER NANOCOMPOSITES AND THEIR USE AS BROAD-SPECTRUM ANTIMICROBIAL AGENTS MATTISON, LORI K —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18259010 GRAPHENE OXIDE-CATIONIC SILVER NANOCOMPOSITES AND THEIR USE AS BROAD-SPECTRUM ANTIMICROBIAL AGENTS MATTISON, LORI K —

Top Art Units

Art UnitApps
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18259010 GRAPHENE OXIDE-CATIONIC SILVER NANOCOMPOSITES AND THEIR USE AS BROAD-SPECTRUM ANTIMICROBIAL AGENTS MATTISON, LORI K 1619 §103Other Non-Final OA — Pending Jun 22, 2023

Managing Zentek Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Zentek Ltd. have?

Zentek Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Zentek Ltd. applications?

Lori K Mattison has the most, with 1 of Zentek Ltd.'s pending office actions.

What technology area are Zentek Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month